DATA BOOK

Product catalog summary

Overview: This document provides an analysis of Kawasumi Laboratories, Inc.'s operations and financial performance from 2007 to 2015, focusing on two main business segments: Blood Transfusion and Endovascular, and Hemodialysis and Plasmapheresis.

Business Segments:

Blood Transfusion and Endovascular: This segment includes products such as blood bags, collection devices, and apheresis kits, as well as minimally invasive products like catheters and stent grafts for endovascular repair.
Hemodialysis and Plasmapheresis: The company offers disposable products for hemodialysis, including dialyzers and blood tubing lines, and plasmapheresis products like apheresis machines and filters.

Financial Data: The document details financial metrics such as net sales, operating income, net income, total assets, and net assets from 2007 to 2015, along with key financial ratios like ROA, ROE, equity turnover, and equity ratio.

Cash Flows: Cash flow statements are provided, highlighting cash flows from operating, investing, and financing activities, with a focus on net cash from operating activities and net cash used in investing and financing activities.

Investor Information: As of March 31, 2015, the document outlines the authorized number of shares, total shares issued, and shareholder distribution, including individuals, foreign companies, financial institutions, and other Japanese companies.

Major Shareholders: The document lists major shareholders such as Kuraray Co., Ltd., Asahi Kasei Medical Co., Ltd., Terumo Corporation, and others, with equity percentages calculated based on shares issued and outstanding, excluding treasury shares.

Company Data:

Company Name: Kawasumi Laboratories, Incorporated
Head Office: Shinagawa Intercity Tower B, 9th Floor 2-15-2, Konan, Minato-ku, Tokyo 108-6109 Japan
Representative: Yoshio Sakaya, President and CEO
Established: June 26, 1957
Paid-in Capital: ¥6,642 million
Fiscal Year-End: March 31
Securities Code: 7703 (TSE 2nd Section)
Main Businesses: Manufacturing and sales of medical devices and pharmaceuticals
Subsidiaries and an Affiliate: Includes Kawasumi Laboratories (Thailand) Co., Ltd., Kawasumi Laboratories America, Inc., and others.

Catalog excerpts

Kawasumi has two business segments; "Blood Transfusion and Endovascular" and "Hemodialysis and Plasmapheresis" Blood Transfusion and Endovascular Hemodialysis and Plasmapheresis <Blood Banking and Transfusion> Blood-related medical devices such as Blood Bags, Blood Collection Device, and Apheresis Kits are used for blood collection, production and preserve of blood products. Kawasumi provides these devices to support the demand of safe blood. <Endovascular Repair> Kawasumi develops minimally invasive and highly-functional products such as Catheters and Stent Graft which are used for Endovascular...

Open the catalog to page 2

Consolidated Financial Highlights- (HSR/¥ Million) ■ USS-mirtWa / Blood Transfusion and Endovascular Operating Income (HSR/¥ Million) i^f-USS / Operating income i^f-USS^ / Operating income to net sales : Total Assets l^7U — •^FVy^J.'yn— Free Cash Flow Free cash flow = Cash flow from operating activities + Cash flow from investing activities

Open the catalog to page 3

Financial Data- IROA Return on Assets I ROE Return on Equity I ElSft^0$E^ Equity Turnover I §2St^tfc^ Equity Ratio I JmUjtfc^ Current Ratio I HDAE!!:!^ Fixed Ratio ;±: ROA = SS« + e«S («*¥)*)) X100 gS«*B$i* = 5E±?B + Se«*«S*¥eB Sffl&tt* = SfflMtS + »@fll x 100 ROE = SlWtfflffi + g3«*(ISS*¥E)) x 100 gS«*hW = miM + WlM x 100 BStt* = BSHS ^-x 100

Open the catalog to page 4

Capital Expenditures (HSR/¥ Million) (HSR/¥ Million) 11 ^r^mmmm Net income per Share 11 ^fc^TcUMSIS Net Assets per Share 11 ^^TcUIS^^^F^) Annual Cash Dividends per Share Notes: ROA = Ordinary income / Total assets(yearly average) x 100 Equity turnover = Net sales / Equity capital(yearly averag ROE = Net income / Equity capital(yearly average) x 100 Equity ratio = Net assets / Total assets x 100 Current ratio = Current assets / Current liabilities x 100 Fixed ratio = Fixed assets / Equity capital x 100

Open the catalog to page 5

Consolidated Financial Statements I J^lnlJfEi^tP,Ri^ Consolidated Balance Sheets (SBP3 /¥ Million)

Open the catalog to page 6

Consolidated Statements of Cash Flows ^^SBjIi-^'S+l'iyi^n.'^n- Cash flow from operating activities:

Open the catalog to page 7

Investor Information — Company Data Company name Kawasumi Laboratories, Incorporated ^±Wi§P/f Head office Shinagawa Intercity Tower B, 9th Floor 2-15-2, Konan, Minato-ku Yoshio Sakaya President and Chief Executive Officer Paid-in capital Fiscal year-end Securities code Main businesses Manufacturing and sales of medical devices and pharmaceuticals Kawasumi Laboratories (Thailand) Co., Ltd. Kawasumi Laboratories America, Inc. Kawasumi Platech Incorporated ■ ^lC(D^?5E (2015^3^31 BfflE) Share Information (As of March 31, 2015) ^T°Til§$r:iC§§iS Authorized number of shares PlfTjn^lC©l8U(ge«i3£SC) Total...

Open the catalog to page 8

DATA BOOK

DATA BOOK

Catalog excerpts

All Kawasumi catalogs and technical brochures